– USA, PA – Helius Medical Technologies, Inc. (NASDAQ: HSDT | TSX: HSM), a neurotech company focused on neurological wellness, today announced the appointment of Jeffrey S. Mathiesen, CPA, to its Board of Directors, as Chair of the Audit Committee, effective as of June 9, 2020.
“Jeff joins our Board of Directors with more than 25 years of experience as Chief Financial Officer of numerous growth-oriented, technology-based companies, including significant experience in the healthcare sector,” said Philippe Deschamps, CEO and Board Chairman. “I am very honored to welcome such an accomplished financial expert to our Board and look forward to leveraging his expertise as Chair of our Audit Committee.”
About Jeff Mathiesen
Mr. Mathiesen’s career experience includes executive and financial management positions with both public and private companies. He most recently worked for Teewinot Life Sciences Corporation, a privately held global leader in the biosynthetic development and production of cannabinoids and their derivatives for consumer and pharmaceutical products, from March 2019 to December 2019, where he served as Chief Financial Officer and later Advisor to the CEO. Mr. Mathiesen previously served as Chief Financial Officer of Gemphire Therapeutics Inc., a publicly-traded, clinical-stage biopharmaceutical company, from 2015 to 2018. Prior to joining Gemphire Therapeutics, Mr. Mathiesen served as Chief Financial Officer of Sunshine Heart, Inc., a publicly-traded medical technology company, from 2011 to 2015. Mr. Mathiesen began his career at Deloitte & Touche LLP in 1983. He received a B.S. in Accounting from the University of South Dakota and is also a Certified Public Accountant.
Mr. Mathiesen has served as Director and Audit Committee Chair of Sun BioPharma, Inc., a publicly-traded biopharmaceutical company developing therapies for pancreatic diseases, since 2015, NeuroOne Medical Technologies Corporation, a publicly-traded medical technology company providing neuromodulation continuous EEG monitoring and treatment solutions for patients suffering from epilepsy and other nerve-related disorders, since 2017, and eNeura, Inc., a privately-held medical technology company providing therapy for both acute treatment and prevention of migraine, from 2018 to 2020.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first product in development is the Portable Neuromodulation Stimulator.
For more information: https://heliusmedical.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
